iHeart Japan Corporation

iHeart Japan Corporation is developing allogeneic regenerative medical products derived from iPS cells, and selling research tools for cardiotoxicity and efficacy tests. We aim to realize regenerative medicine for heart failure and release patients from waiting heart transplantation .